Insights into the Recent Research Progress on the Synthesis and Pharmacology Approaches of 1,3,4-oxadiazole: A Comprehensive Review

Oxadiazoles are heterocyclic compounds known for their remarkable chemical stability and diverse pharmacological characteristics, making them appealing scaffolds for drug development. This review examines eco-friendly, high-yield synthetic methods-such as microwave-assisted cyclization, catalyst-free dehydrative condensation, and solvent-free grinding-that produce 1,3,4-oxadiazole derivatives with superb atom economy, often yielding over 80%. We review clinically approved medications that contain the 1,3,4-oxadiazole core (e.g., pleconaril, raltegravir, oxolamine) and point out emerging analogues showing strong anticancer, antifungal, and anticonvulsant effects in both experimental settings and in silico assessments. Structure-activity relationship studies indicate how minor changes to the heterocyclic ring can significantly affect target affinity and metabolic stability. Finally, we emphasize the importance of continuing the integration of green chemistry techniques with advanced bioactivity profiling-utilizing in vitro assays, computational modeling, and mechanistic studies-to harness the full therapeutic potential of 1,3,4-oxadiazole derivatives, thereby paving the way for a new generation of more effective, selective, and sustainable drug candidates.